Table 5 Postneonatal outcomes of children exposed to chemotherapy in utero

Child considered healthy

49/50 (98)

–

–

Developmental milestone delays

6/50 (12)

2/6 (33)

10 [22]

Difficulties in school^a

4/37 (11)

3/4 (75)

6-11 [22]

Reported health concerns

31/50 (62)

19/31 (61)

–

Allergies/eczema

18/50 (36)

12/18 (67)

11 to 25 [22]

Asthma/breathing

5/50 (10)

4/5 (80)

13 [22]

Vision

8/50 (16)

5/8 (63)

14 [22]

Heart murmur^b

1/50 (2)

–

1.3 [23]

“Lazy eye”

2/50 (4)

1/2 (50)

1.6 to 3.6 [24]

Absence seizures^c

1/50 (2)

1/1 (100)

<1 [25]

ENT^d

4/50 (8)

3/4 (75)

HL, <1; ROM, 18 to 26^d [26]

GERD^e

2/50 (6)

2/2 (100)

5 to 67^f [27]